POINT Biopharma Global Inc.‘s stocks are currently a part of 62 hedge funds’ portfolios, which represents 15.9% of the total amount of its stocks outstanding. This makes up a total of 15.26M shares of POINT Biopharma Global Inc.. Compared to the previous quarter, the number fell by -75.02% or -45.85M shares fewer. As for the holding position changes, 29.03% (18) of current hedge fund investors increased the number of shares held, 30.65% (19) of current holders sold a part of the shares held, and 11.29% (7) closed the holdings completely. 14 hedge funds are new holders of POINT Biopharma Global Inc. stock in Q1 2023, it is 22.58% of total holders.